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Summary
Macroautophagy is a main catabolic pathway of eukaryotic
cells, delivering cytoplasmic constituents for lysosomal de-
gradation. Originally described as a starvation response, it
has now been realised that macroautophagy supports many
aspects of innate and adaptive immunity by facilitating in-
nate pathogen detection and antigen presentation, as well
as pathogen clearance and lymphocyte expansion. In the
first half of this review, we summarise new insights into
substrate selection and macroautophagic support of vesi-
cular transport pathways, which underlie macroautophagic
regulation of afferent and efferent immunity to pathogens,
as outlined in the second half of the review. Applying this
increased mechanistic understanding to infectious disease
settings should allow us to identify further pathways for
pathogen restriction, which can be explored for therapeutic
manipulations of macro-autophagy.
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Introduction
Eukaryotic cells primarily use two catabolic systems to de-
grade their cytoplasmic constituents, the proteasome and
autophagy. While proteasomal degradation requires the
substrates to be unfolded by chaperones, autophagy can
turn over protein aggregates and even whole cell organelles
in lysosomes. The later ability enables autophagy to also
target cytosolic pathogens, whole bacteria and viruses [1,
2] for degradation, as an effector mechanism of adaptive
and innate immunity (efferent arm of the immune re-
sponse), and to deliver pathogen fragments for pathogen
associated molecular pattern (PAMP) sensing and antigen
presentation (afferent arm of the immune response) [3].
Both immunological and metabolic functions of autophagy
use the same molecular core machinery. Of the three auto-
phagic pathways, macro-, micro- and chaperone-mediated
autophagy, macroautophagy is best understood in this re-
spect (fig. 1). More than 30 essential autophagy-related
gene (Atg) products contribute to autophagosome form-
ation and degradation [4, 5]. Of these, we only want to
highlight three complexes, which are primarily utilised for
monitoring and manipulation of macroautophagy, both by
scientists and pathogens. The first of these seems to de-
termine the site of autophagosome generation as well as
catalysing autophagosome degradation and involves Atg6/
Beclin-1. This protein associates with the class III phos-
phatidylinositol-3–OH (PI3) kinase Vps34 and the myris-
toylated membrane anchoring protein Vps15. Depending
on the other participants in the complex, the Atg6/Vps34
can initiate autophagosome formation (together with At-
g14) at the rough endoplasmic reticulum, the Golgi appar-
atus, mitochondria, outer nuclear or cell membrane [6–13],
and augment or inhibit autophagosome fusion with lyso-
somes (together with UVRAG or Rubicon, respectively).
Due to the crucial function of these class III PI3 kinase
complexes, Atg6/Beclin-1 is modulated by many patho-
gens, by the anti-apoptotic proteins Bcl-2 and Bcl-XL, as
well as by mutations in cancer [14–16]. The second com-
plex, downstream of PI3 labelling of the membrane sites
for autophagosome generation, is generated by the
Figure 1
The two ubiquitin-like conjugation systems of macroautophagy.
Autophagosomes form at PI3P marked membrane domains. At
these pre-autophagosomal structures, Atg12 gets coupled to Atg5
and associates with Atg16L1 to conjugate Atg8/LC3 (after cleavage
by Atg4 and activation by Atg3 and 7) to the autophagosomal
membrane. Following autophagosome completion, the outer
autophagosome membrane looses its Atg decoration in a
Atg4-dependent manner, while Atg8/LC3, coupled to the inner
autophagosomal membrane, is degraded with the autophagosome
cargo after fusion with lysosomes.
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ubiquitin-like coupling of Atg12 to Atg5. This is assisted
by the E1-and E2-like enzymes, Atg7 and Atg10. The At-
g12 conjugate with Atg5 then associate with Atg16L1 to
form an E3–like ligase for the conjugation of the ubiquitin-
like molecule Atg8/LC3 to the autophagosomal membrane,
after Atg8/LC3 has been proteolytically processed by Atg4
and activated by the E1- and E2-like enzymes Atg7 and At-
g3. While the Atg12 complex and Atg8/LC3 get recycled
from the outer autophagosomal membrane, the later by At-
g4, Atg8/LC3 stays associated with the inner autophago-
somal membrane and gets degraded in lysosomes togeth-
er with the macroautophagy substrates. Atg8/LC3 supports
membrane hemifusion during the elongation of the auto-
phagosomal membrane and forms the membrane anchor
for substrate recruitment into the autophagosomal mem-
brane [17, 18]. This core machinery allows flexible form-
ation of small autophagosomes (0.5–1 μm in diameter) for
metabolic purposes, as well as large xenophagosomes (up
to 10 μm in diameter) for the engulfment of cytosolic bac-
teria, using membranes from multiple sources.
Substrate selection for autophagy
While macroautophagy was originally considered a non-
discriminatory degradation process for cytoplasmic mater-
ial in lysosomes, it has recently become apparent that its
different substrates are selectively imported into autopha-
gosomes and that, even during starvation, a hierarchy of
sequential cytoplasm degradation exists [19]. Interestingly,
poly-ubiquitination, which also targets soluble substrates to
proteasomal degradation, selects substrates for macroauto-
phagy towards lysosomal degradation. This selection of
poly-ubiquitinated substrates into autophagosomes seems
to be mediated by proteins that contain both ubiquitin bind-
ing domains (UBA or UBZ) and LC3 interacting motifs
(LIRs: WXXL or WXXI), and directly anchor the mac-
roautophagy substrates to the inner autophagosomal mem-
brane. Three such proteins have so far been identified in
mammalian cells: p62/sequestosome 1, NBR1 and NDP52
[18, 20–22]. They mediate the recruitment of protein ag-
gregates, modified by the chaperone- associated ubiquitin
ligase CHIP, into autophagosomes. The chaperone BAG3
cooperates with p62/sequestosome 1 in the macroauto-
phagy of these poly-ubiquitinated protein aggregates
[23–26]. Furthermore, p62/sequestosome 1, assisted by its
interacting protein Alfy, promotes protein aggregation for
macroautophagic substrate generation [27, 28]. In addition
to protein aggregates, ubiquitination of mitochondria via
the ubiquitin ligase Parkin might facilitate their recruitment
to autophagosomes [29]. In contrast to higher eukaryotes,
the yeast Saccharomyces cerevisiae has no obvious homo-
logues of p62/sequestosome 1, NBR1 and NDP52 [30],
and ribosomal degradation by macroautophagy is even en-
hanced by deubiquitination [31]. Instead, the yeast ex-
presses LIR containing proteins like Atg9 that directly in-
teract with enzymes, such as aminopeptidase 1 and α-man-
nosidase 1, which are imported into the lyosomal vacuole
by the macroautophagy-related biosynthetic cytoplasm-to-
vacuole (Cvt) pathway [32]. Furthermore, in yeast, Atg32
was reported to recruit mitochondria to autophagosomes
[33, 34]. This later mechanism seems to be conserved,
since the outer mitochondrial membrane protein NIX of
mammalian cells also contains a LIR and assists in mac-
roautophagy of mitochondria [35, 36]. Thus, both poly-
ubiquitination dependent and independent substrate recruit-
ment to macroautophagy exist. While yeast seems to em-
ploy LIR containing proteins that directly bind to autopha-
gosome cargo, mammalian cells have, in addition, deve-
loped proteins that cross-link ubiquitin and LC3 to allow
macroautophagy of poly-ubiquitinated substrates. This al-
lows a much more versatile use of macroautophagy, util-
ising the sophisticated mammalian system of ubiquitin lig-
ases for protein degradation.
Vesicular transport pathways assisted
by autophagy
The eukaryotic endomembrane system includes endoplas-
mic reticulum (ER), Golgi and lysosomes. Macromolec-
ules, such as proteins and lipids, are exchanged between
these organelles and the extracellular space through vesicu-
lar transport. This movement is bidirectional and therefore
vesicles can deliver their cargo from trans-Golgi to stor-
age vesicles, to the lysosomes or to the plasma membrane,
or follow the reverse route [37]. Growing evidence, which
is summarised below, demonstrates that autophagy can as-
sist both secretory and endocytic pathways. This may not
be so surprising considering that the machinery required
for macroautophagy, especially for autophagosome matur-
ation, overlaps with other membrane trafficking pathways.
This is the case for some subunits of the endosomal sort-
ing complex required for transport (ESCRT), like for ex-
ample Vps4, Vps25, Vps28 or Vps32, which have been
shown to be essential for generation of fully degradative
autophagosomes in flies [38]. Furthermore, Vps34, a PI3K
that was first described to target proteins containing the
phosphoinositide-binding domain to endosomal/lysosomal
vesicles, regulates both autophagosome generation and
maturation in yeast as well as in mammalian cells [39]. The
cross-talk between classical vesicular transport and auto-
phagy is further exemplified by the Rab family of proteins.
Rabs are peripheral membrane-bound GTPases that reg-
ulate membrane trafficking (vesicle formation, movement
and fusion). A recent study using fly models suggests that
Rab5 supports early macroautophagy processes in a way
that is independent of its endocytic functions [40]. Pre-
autophagosomal structures seem to be assembled around
Figure 2
Macroautophagy in pathogen restriction and replication. Pathogens,
like viruses, bacteria and parasites, can be degraded by
macroautophagy, or might use autophagosomal delivery to multi-
vesicular bodies for their release from the host cell. In addition,
viruses re-model cytoplasmic membranes via macroautophagy in
order to replicate on their surface.
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complexes containing Rab5, Vps34 and Beclin-1. Since in-
hibition of Rab5 decreases autophagosome formation, but
leads to accumulation of autophagosome precursors, the
authors suggested that Rab5 would act as an activator of
Vps34, an essential component for the progression of auto-
phagosome formation. Moreover, late endosomal Rabs,
such as Rab7 and Rab11, were proposed to promote auto-
phagosome fusion with lysosomes and multi-vesicular bod-
ies (MVB), respectively [41, 42], further supporting the
intersection of both vesicular trafficking and macroauto-
phagy machinery. Thus, macroautophagy seems to make
use of common mechanisms and components of vesicular
trafficking.
Apart from the shared use of this molecular machinery by
macroautophagy and other vesicular transport processes,
there are recent data suggesting that proteins essential for
macroautophagy can effectively assist exocytosis. This is
the case for the unconventional secretion of acyl co-en-
zyme A-binding protein (Acb1) in Saccharomyces cerevi-
sae, which requires Atg5, 7, 8 and 12, but not secretory
pathway components such as Sec1, 7 and 23 [43]. This
study also suggested that autophagosomes sequester Acb1
but do not proceed to normal maturation by fusing with
the lysosomal compartment (yeast vacuole). Instead,
Acb1–containg autophagosomes are redirected to the
plasma membrane, in a process involving MVBs and the
t-SNARE Sso1, ultimately releasing their content in the
extracellular space. This interpretation is supported by the
fact that deletion of essential mediators of autophagosomal
fusion with the vacuolar membrane (Vam3 and Ypt7) does
not inhibit Acb1 secretion. Another study making use of
yeast genetics further supports a role for macroautophagy
in unconventional protein secretion. Indeed, Manjithaya et
al. showed that, similar to what was observed in S. cerevi-
sae, in the yeast Pichia pastoris core Atg proteins (Atg1, 6,
8 and 17) are necessary for Acb1 secretion [44]. Moreover,
adding rapamycin to cell cultures enhanced Acb1 secretion
in wild type cells but not in Atg1 knock-out mutants. To-
gether, these studies provide evidence for a role of mac-
roautophagy in unconventional protein secretion. However,
direct proof of the involvement of whole autophagosomes
capturing Acb1 as a specific substrate has yet to be ob-
tained. Concerning macroautophagy-assisted exocytosis,
some other examples are worth mentioning. For instance,
macroautophagy seems to contribute to non-lytic viral re-
lease to the extracellular space (fig. 2). This has been sug-
gested for polio viruses, adenoviruses and the human im-
munodeficiency virus, based on the observation that fol-
lowing infection double membrane vesicles, similar to
autophagosomes, accumulate in the cytoplasm and even
without breakdown of the host cell plasma membrane, a
significant amount of virions can be found in culture me-
dium [45–47]. Furthermore, it was recently suggested that
corona-viruses induce formation of autophagosome-like
vesicles that seem to be dependent on LC3–I but, in-
triguingly, not on its lipidated form (LC3–II) or on any oth-
er essential macroautophagy gene products [48]. So far we
can only speculate that LC3–I could then act as a coat-
ing protein that would signal vesicle biogenesis. Altogeth-
er, these data suggest that macroautophagy facilitates exo-
cytosis during unconventional protein secretion and viral
replication.
In the opposite direction, macroautophagy has been repor-
ted to assist phagosomal maturation [49, 50]. This process
was suggested to depend on recruitment of LC3 and Be-
clin-1 to phagosomes, which will then, through a still un-
known mechanism, promote lysosomal fusion to the pha-
gosome, boosting phagosomal content degradation. As
with coronavirus replication, parts of the macroautophagy
machinery seem to be used for phagosome maturation, and
elucidation of the role of Atgs in these vesicular transport
pathways will probably also define their function during
classical macroautophagy more clearly.
Pathogen restriction by autophagy
In its more classical form, macroautophagy as a catabolic
pathway can directly target and destroy intracellular patho-
gens (fig. 2). Indeed, several studies report an increased
susceptibility of infection following deletion of macroauto-
phagy components. However, initial signalling events that
lead to microbial engulfment by isolation membranes re-
main poorly understood. Still, one may speculate that these
involve poly-ubiquitination or Atg recruitment domains, as
previously addressed in section 2 of this review. Examples
of pathogen restriction by macroautophagy can be found
in bacterial, parasitic and, to a lesser extent, in viral infec-
tions. For example, Listeria monocytogenes evades the ex-
treme conditions of the phagosome to grow in the cytosol,
by escaping through listeriolysin-O (LLO) formed pores
in the phagosomal membrane. The damage induced to the
phagosomal membrane was suggested as a trigger for mac-
roautophagy [51]. In the cytosol, Listeria surrounds itself
with an actin coat to escape engulfment by autophago-
somes, and only ActA- deficient bacteria are efficiently
degraded by macroautophagy [52]. Similarly, Shigella ex-
presses the IcsB protein that blocks binding of Atg5 to its
VirG protein to prevent incorporation into autophagosomes
[53]. In contrast, however, many other cytosolic patho-
gens, like group A Streptococcus, Francisella tularensis or
Rickettsia conorii, are restricted by macroautophagy and
this innate defence is defective in Atg5- deficient mac-
rophages [1, 5]. Apart from targeting cytosolic microbes,
macroautophagy can also influence the control of patho-
gens, which live and replicate inside vesicular compart-
ments. This is the case for Mycobacterium tuberculosis,
macrophage phagosome-resident bacteria that are capable
of interfering with phagosomal maturation pathways. Ini-
tial studies in murine cell lines demonstrated that induction
of autophagy can counteract the pathogen-induced remod-
elling of phagosomes by promoting phagosome acidific-
ation and subsequent mycobacteria clearance [54]. This
process involves the immunity-related GTPase family M
(IRGM), and in accordance, human genetic approach stud-
ies identified protective IRGM gene variants against M.
tuberculosis [55]. Furthermore, several other macroauto-
phagy genes have been found in a recent M. tuberculosis
resistance gene screen [56]. In addition to mycobacteria,
the protozoan Toxoplasma gondii, which also conditions
phagosomes as its replication niche, can either be directly
targeted by autophagosomes following disruption of the
vesicle harbouring the parasite, or the whole parasitophor-
ous vacuole can be re-routed to lysosomes in an autophagy-
dependent fashion [50, 57]. Thus, macroautophagy can re-
strict bacterial and parasitic pathogens, but some of them
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have developed escape mechanisms against this mechan-
ism of innate immunity.
In addition to the strategies presented above, autophagy can
also act on the reduction of bacterial load through the deliv-
ery of sources for antimicrobial peptides to microbe-con-
taining vesicles. Some of the bactericidal components iden-
tified so far have been ubiquitin-derived peptides, which
are generated by lysosomal proteolysis after delivery to
bacteria containing phagosomes via macroautophagy.
These are either directly derived from poly-ubiquitinated
autophagosome content or Fau, a ribosomal protein con-
taining an ubiquitin domain [58, 59]. In the case of Fau,
p62/sequestosome 1 links this source of bactericidal pep-
tides to LC3 for engulfment by autophagosomes. Thus,
macroautophagy does not only restrict bacterial pathogens
by degradation in lysosomes, but also increases bactericidal
activity of these compartments by delivering proteins,
which are processed to bactericidal peptides.
In addition to innate restriction of bacterial and parasitic in-
fections, macroautophagy has also been reported to restrict
viral infections, although the underlying mechanisms are
still mostly unclear. The existing studies have mainly estab-
lished a correlation between Atg gene function and control
of viral replication. For example, the plant mosaic virus in-
fection seems to be controlled by Atg3, Atg7, Beclin-1 and
Vps34 [60]. Similarly, depletion of Atg5, Atg8a, Atg18 and
other autophagy related genes significantly increased vesi-
cular stomatitis viral loads in Drosophila [61]. In addition
to these invertebrate in vivo systems, neuronal control of
herpes simplex virus (HSV) or Sindbis virus infections by
macroautophagy has been recently described [62, 63]. HSV
that lacked the macroautophagy-inhibitory domain of the
ICP34.5 protein, replicated to lower viral loads and caused
decreased pathology after intracerebral infection. Similarly,
Sindbis virus infection in the central nervous system was
aggravated if macroautophagy was compromised by dimin-
ishing Atg5 levels in infected neurons. In the later study,
the authors demonstrated that Atg5 silencing was not gen-
erally required for Sindbis virus replication in immortal-
ised cell lines, however, neuronal Atg5 function was rather
important in clearance of Sindbis virus antigens and for
protection of neurons against cell death. Therefore, mac-
roautophagy does not seem to directly impact pathogen
replication, but rather promotes host cell resistance to in-
fection.
Innate pathogen sensing via
autophagy
In addition to its direct role in intracellular pathogen target-
ing, macroautophagy can also regulate the microbial fate
by mediating pathogen detection and influencing the host
cell inflammatory responses. This was proposed for the re-
cognition of vesicular stomatitis virus (VSV) by toll-like
receptor 7 (TLR7) in plasmacytoid dendritic cells (pDCs),
which is negatively influenced upon inhibition of mac-
roautophagy [64]. Indeed, after VSV infection, both phar-
macological inhibition of macroautophagy and Atg5
knock-out in murine cells, resulted in diminished secretion
of IFN-α: a hallmark cytokine in response to RNA virus
infection. Furthermore, delivery of B cell receptor ligands
to TLR9 containing vesicles for CpG DNA detection was
found to be dependent on macroautophagy [65]. In contrast
to pDCs and B cells, other cell types sense viral genomes
and transcription products through cytosolic receptors of
the Rig-1–like receptors family (RLRs). Jounai et al. [66]
demonstrated that in mouse embryonic fibroblasts (MEFs)
the absence of Atg5 significantly increased type I IFN
production in response to dsRNA. According to the au-
thors, the Atg5–Atg12 complex suppresses IFN-α produc-
tion through direct interaction with the CARD domain of
both IPS-1 and RIG-I. In agreement, a more recent study
demonstrated that Atg5–/– MEFs and primary murine liver
macrophages produce higher type I IFN levels upon RIG-
I stimulation [67]. This enhancement of RLR signalling in
the absence of macroautophagy is linked to the accumula-
tion of dysfunctional mitochondria, which present an un-
balanced redox status, leading to augmented reactive oxy-
gen species (ROS) levels that can directly stimulate RLR.
Similarly, absence of macroautophagy enhances inflamma-
some activation [68], and this also seems to require mito-
chondrial ROS production [69, 70]. Thus, depending on the
pathogen associated molecular pattern (PAMP) and the de-
tecting cell, macroautophagy can either restrict or augment
the PAMP recognition signalling mechanisms.
In addition to virus detection, macroautophagy also regu-
lates bacterial sensing. Following Shigella infection, pha-
gosome rupture generates membrane remnants that are tar-
geted for elimination by macroautophagy due to a poly-
ubiquitination process that recruits LC3 and p62 [71]. With
this, macroautophagy can silence the signalling cascades
activated by PAMPs and danger-associated molecular pat-
terns (DAMPs) contained in the Shigella vacuole mem-
brane remnants, including NF-κB-dependent cytokine pro-
duction, ROS production and cell death. Therefore, by
eliminating signal molecules implicated in adverse host
cell effects, macroautophagy might work as a pro-survival
factor following bacterial infections.
On the other hand, innate immune sensing pathways can
induce the macroautophagy pathway. Along these lines,
stimulation of cells with several TLR agonists, such as
Pam3Cys4, zymosan, polyinosinic:polycytidylic acid, lipo-
polysaccharide, single stranded RNA and imiquimod, was
suggested to up-regulate macroautophagy [5]. Since most
of these studies were performed in the murine Raw264.7
cell line, one must be cautious when generalising these
findings to other cell types, especially to primary cells. In
fact, there are some conflicting data regarding the TLR-
dependent induction of macroautophagy. Immunofluores-
cence analysis of primary macrophages from C57BL/6
mice treated with TLR2, 3, 4, 5, 7, 8 and 9 agonists did not
induce an increase in LC3 positive vesicles [68]. However,
this contrasts with what was observed in primary murine
macrophages of Atg7+/– mice [49], in bone-marrow-derived
macrophages from knock-in GFP-LC3 transgenic mice
[72], and in primary human alveolar macrophages [73].
Especially in the later cell population, TLR4 and TLR7
stimulation have been suggested to target vacuolar myco-
bacteria for degradation [72, 73]. Apart from TLRs, stimu-
lation of other pattern recognition receptors also regulates
macroautophagy. In DCs, NOD2 receptor stimulation with
muramyldipeptide induces macroautophagy in an Atg5-, 7-
and 16L1-dependent manner [74]. Here, NOD2–induced
macroautophagy results in bacteria restriction and in-
creased MHC class II antigen presentation. Interestingly,
both NOD2 and Atg16L1 were identified as susceptibility
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genes for Crohn’s disease [75–78], and patients’ DCs are
deficient in MHC class II up-regulation after NOD2 stimu-
lation [74]. In conclusion, these studies suggest that specif-
ic PAMP recognition can regulate macroautophagy.
Support of adaptive immunity by
autophagy
The degradation in lysosomes via macroautophagy also
generates proteolytic fragments that can be presented on
MHC molecules to T cells (fig. 3). In this respect, CD4+,
so-called helper T cells (the orchestrators of adaptive im-
munity), primarily recognise lysosomal degradation
products presented on MHC class II molecules, while
CD8+, so-called cytotoxic T cells (the main effectors of
cell-mediated adaptive immune responses), are stimulated
by mainly proteasomal products presented on MHC class
I molecules. Accordingly, macroautophagy has primarily
been documented to deliver antigens for MHC class II
presentation [79]. This includes cytosolic model antigens
[80–82], viral [83–85], intracellular bacteria derived [86,
87] and self-antigens [88]. The self-antigen presentation on
MHC class II molecules after macroautophagy by thym-
ic epithelial cells has been shown to shape both positive
and negative T cell selection in mice [89]. In the absence
of Atg5, some clonal CD4+, but not CD8+, T cell spe-
cificities were inefficiently positively selected on cortical
thymic epithelial cells, and a T cell repertoire was gener-
ated that was inefficiently tolerised by negative selection
on medullary thymic epithelial cells, and, therefore, elicited
autoimmune pathology in several tissues. In addition to
this role for macroautophagy in self-antigen presentation
on MHC class II molecules during T cell education, mac-
roautophagy enhanced mycobacterial antigen presentation
in DCs for vaccination [86], and was also essential in DCs
to prime strong CD4+ T cell responses during HSV infec-
tion [90]. During HSV infection, the viral gene product
ICP34.5 antagonises macroautophagy, and ICP34.5 defi-
cient HSV infection primes elevated CD4+ T cell re-
sponses, which control viral titers at lower levels [91].
These studies suggest that macroautophagy contributes to
Figure 3
Macroautophagy in antigen processing for MHC presentation.
Proteasomal products are primarily presented on MHC class I
molecules to CD8+ T cells, while lyosomal products are
preferentially presented on MHC class II molecules to CD4+ T cells.
Macroautophagy seems to contribute to antigen presentation in at
least three ways: i) it delivers cytoplasmic antigens for MHC class II
presentation, ii) enhances phagosome maturation and iii) packages
antigens in bystander cells for more efficient cross-presentation by
antigen presenting cells.
adaptive immune responses by facilitating pathogen-de-
rived antigen processing for MHC class II presentation, and
shaping the CD4+ T cell repertoire via self-antigen present-
ation on MHC class II molecules in the thymus.
Apart from the fairly extensive evidence for a role of mac-
roautophagy in MHC class II antigen presentation, a few
reports also suggest that this pathway can assist in MHC
class I presentation of antigens. It was suggested that mac-
roautophagy is required, late during HSV infection, for in-
tracellular antigen processing onto MHC class I molecules
[10]. Surprisingly, the authors proposed that autophago-
some contained antigens would leave these vesicles again
for further proteasomal processing and loading onto MHC
class I molecules for CD8+ T cell stimulation. Further-
more, cross-presentation of antigens for MHC class I
presentation by bystander antigen presenting cells was pro-
posed to require macroautophagy in the antigen donor cell
[92, 93]. The mechanism of this antigen packaging for ef-
ficient cross-presentation, however, remains unclear. Thus,
macroautophagy might, under certain conditions, also con-
tribute to antigen processing for MHC class I presentation
to CD8+ T cells.
In addition to this role in antigen presentation, macroauto-
phagy also seems to be required for survival of lymphocyte
populations during development and immune responses.
T cells particularly require macroautophagy for surviving
thymic education and expansion during immune challenges
[94]. Atg7-deficient T cells and their precursors accumu-
late mitochondria and expanded endoplasmic reticulum
[95, 96]. The accumulation of damaged mitochondria el-
evates ROS levels, resulting in decreased survival of de-
veloping and stimulated macroautophagy-deficient T cells.
In addition to T cells, B cells, in particular B-1a cells, re-
quire macroautophagy for their development [97]. In con-
trast to the macroautophagy dependency of haematopoietic
progenitor cell maintenance and lymphocyte development
[98–100], macrophages, conventional DCs and pDCs do
seem to develop normally in the absence of macroauto-
phagy [64, 90, 101]. This offers the possibility to invest-
igate adaptive immune responses for roles of macroauto-
phagy in antigen processing and pathogen sensing by my-




Macroautophagy contributes to both adaptive and innate immunity.
Antigen presentation and lymphocyte populations are regulated by
macroautophagy during adaptive immune responses. In addition,
pathogen sensing and their degradation are also supported by this
catabolic pathway.
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Macroautophagy interfaces with many aspects of innate
and adaptive immunity (fig. 4), both for pathogen sensing
and elimination. While in vivo immunological restriction
of these bacteria, viruses and parasites is, mechanistically,
still poorly understood, the new insights into substrate se-
lection by macroautophagy and its support for various vesi-
cular trafficking pathways now allow researchers to dissect
which pathogens are especially prone to be targeted by
macroautophagy and which cellular pathways are used.
This should permit us to identify infectious disease set-
tings, in which macroautophagy manipulation can be ex-
plored for clinical benefits.
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